General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Registration

Information for Speakers, Presenters and Chairs

Program

Sessions

Search presentations

General information 2

Abstract Submission (Oral/Poster Presentation)

pharm143_en.png

icon_20251203182619268.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

<br>Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Download PDF for print

Timetable

Use of AI technology and its applicability to risk assessment in the medical and other fields

The use of statistical analysis and AI technology is indispensable for research from omics analysis to genome drug discovery and personalized medicine. Advanced research is also ongoing to discover disease-related genes and elucidate pathological conditions through integrated analysis of genome cohort information using Biobanks, and to link this to drug discovery. At the same time, the number of situations in which data of different natures, such as omics data and medical data, are handled simultaneously is increasing, and the establishment of analysis methods is also progressing. In addition, in silico prediction has become a very important research field in the field of risk assessment.<br />In the first half of the symposium, leading researchers in these research fields will talk about "Statistical genetics, disease biology, drug discovery, and personalized medicine" and "Data-driven drug target discovery by subset binding, a stratification algorithm that links heterogeneous data". The second half will focus on "Development of a new in silico allergen prediction method using machine learning and deep learning" and "Use of AI technology and its applicability to risk assessment in the medical and other fields". <br />In this symposium, we would like to share the current status, challenges, and approaches of the latest research on genomic drug discovery and personalized medicine, and at the same time, we would like to help you develop your research by further advancing your understanding of how AI is used and the challenges it faces in the field of risk assessment. We hope that this symposium will help you to develop your research.

Current status and challenges of research for genomic medicine and food safety using large-scale data

The 143rd Annual Meeting of the Pharmaceutical Society of Japan (Sapporo)

Presentation Information

[S14-04]Use of AI technology and its applicability to risk assessment in the medical and other fields

Password required to view